Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

105.66
Delayed Data
As of 4:03pm ET
 +0.71 / +0.68%
Today’s Change
92.28
Today|||52-Week Range
157.99
-31.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line266.9M360.9M484.8M541.3M
 
 
 
 
 
Depreciation17.8M16.6M15.8M14.8M
 
 
 
 
 
Total Other Cash Flow1.1M-7.6M-12.7M-11.9M
 
 
 
 
 
Funds From Operations266.9M346.1M417.5M532.3M
 
 
 
 
 
Funds From/For Other Operating Expenses18.2M-11.6M10.7M137.2M
 
 
 
 
 
Net Cash Flow - Operating Activities248.7M357.6M406.8M395.1M
 
 
 
 
 
 
InvestingIncrease In Investments-241.7M-120.7M-43.3M-220.2M
 
 
 
 
 
Decrease In Investments4.8M7.2M111.0K--
 
 
 
 
Capital Expenditures-9.5M-21.2M-20.0M-19.0M
 
 
 
 
 
Fixed Asset Disposal1.0K8.0K217.0K0.00
 
 
 
 
Other Investing - Uses-5.0M-34.0M-31.1M-80.6M
 
 
 
 
 
Other Investing - Sources8.2M0.002.1M35.0M
 
 
 
 
Net Cash Flow Investing-243.9M-173.3M-92.1M-284.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-10.7M-11.9M-10.9M-5.9M
 
 
 
 
 
Net Proceeds Stock Sale6.6M1.3M26.0K0.00
 
 
 
 
Common Preferred Redeemed0.00-193.0M0.00-9.5M
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing838.0K149.0K0.000.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-3.3M-203.5M-10.9M-15.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.4M-8.2M-32.1M57.0K
 
 
 
 
 
 
Net Change In Cash1.4M-19.1M303.8M94.9M